Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 29, 2011 12:15 ET | Source: Myrexis, Inc.

Myrexis Reorganizes to Align Resources With Current Pipeline

SALT LAKE CITY, March 29, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced a...
March 17, 2011 16:00 ET | Source: Myrexis, Inc.

Myrexis to Provide Update on Heat Shock Protein 90 and Cancer Metabolism Inhibitor Programs at 102nd Annual Meeting of American Association for Cancer Research

SALT LAKE CITY, March 17, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today...
March 16, 2011 16:00 ET | Source: Myrexis, Inc.

Myrexis to Present at 10th Annual Needham Healthcare Conference

SALT LAKE CITY, March 16, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today...
February 16, 2011 08:00 ET | Source: StudioEX

Facebook Users Find New and Improved Galaxy X Futile to Resist

LOS ANGELES, CA--(Marketwire - February 16, 2011) - StudioEX today announced an update to Galaxy X, its popular turn-based ballistic action game for Facebook. Facebook users have definitely...
February 09, 2011 16:15 ET | Source: Myrexis, Inc.

Myrexis Reports Second Quarter Fiscal 2011 Financial Results

AzixaTM Two-Arm Phase 2b Study in Glioblastoma Initiated Conference Call Today at 4:30pm EST Upcoming Events Report Phase 2 monotherapy results in recurrent glioblastoma multiforme (GBM)...
February 03, 2011 09:00 ET | Source: Myrexis, Inc.

Myrexis Announces Azixa(TM) Clinical Data Publications

Phase 1 Clinical Data Published by Molecular Cancer Therapeutics Pre-Clinical, Phase 1 and 2 Clinical Data Review Published by Drugs of the Future SALT LAKE CITY, Feb. 3, 2011 (GLOBE NEWSWIRE)...
February 01, 2011 09:00 ET | Source: Myrexis, Inc.

Myrexis to Hold Conference Call to Discuss Fiscal Second Quarter 2011 Financial Results

SALT LAKE CITY, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today...
January 12, 2011 07:28 ET | Source: Digital Ally, Inc.

Ken McCoy Joins Digital Ally Board of Directors

OVERLAND PARK, KS--(Marketwire - January 12, 2011) - Digital Ally, Inc. (NASDAQ: DGLY), which develops, manufactures and markets advanced video surveillance products for law enforcement, homeland...
December 22, 2010 16:19 ET | Source: Myrexis, Inc.

Myrexis Initiates Comparative-Arm Phase 2 Study of Azixa(TM) for the Front-Line Treatment of Glioblastoma Multiforme

SALT LAKE CITY, Dec. 22, 2010 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today...
December 21, 2010 11:58 ET | Source: StudioEX

StudioEX Receives $1.9 Million in Funding From Prominent International Private Investors

LOS ANGELES, CA--(Marketwire - December 21, 2010) - Founded in 2009, StudioEX is a leading global developer of browser-based games for the Windows and Mac platforms. StudioEX is part of the...